Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07130708 · ClinicalTrials.gov registry record · NA

Exploring the Potential of Robotic Telesurgery in Remote Settings

A NA study of Prostate Carcinoma and Prostate Disease, sponsored by AdventHealth.

Recruiting
Registry status
NA
Development phase
10
Enrollment target
1
Study location

NCT07130708: Recruiting NA study of Prostate Carcinoma and Prostate Disease, sponsored by AdventHealth.

NCT07130708 is a NA study of Prostate Carcinoma and Prostate Disease that is actively recruiting participants, run by AdventHealth. The registered enrollment target is 10 participants, below the 1,502-participant average among 59 other Prostate Carcinoma trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07130708, a NA study of Prostate Carcinoma and Prostate Disease, is actively recruiting participants, sponsored by AdventHealth.

RECRUITING
Registry status
NA
Development phase
10 participants
Enrollment target
1
Study location

Study Summary

This study involves a type of robotic surgery called telesurgery, where a highly trained surgeon performs the surgical procedure using a secure internet connection to operate on a patient in a different location. Urologists from The goal of this study is to find out how safe and effective telesurgery is when used in real hospitals. The study aims to understand how well Telesurgery works in different settings, what technical challenges might come up (like internet speed or delays), and how it can be used to train new surgeons.

Primary Outcome

One of the investigator's primary outcome measures is the safety and feasibility of the Microport Medbot Robotic Platform for use in Telesurgery through maintaining a stable connection. The investigator will monitor feasibility through perioperative connectivity assessment provided by the platform. Outcome of Latency- Medbot platform measures in milliseconds. This is monitored by the investigator. Measured in Milliseconds per round trip time (ms/RTT). The acceptable threshold is under 200ms. R

Interventions

  • DEVICE Telesurgery utilizing Microport Medbot Robotic Platform

Study Locations (1)

Florida

  • AdventHealth - Celebration

Trial Details

FieldValue
Enrollment Target 10 participants
Start Date 2025-06-14
Est. Completion 2033-07-30
Phase NA
AdventHealth

95 total trials

What NCT07130708 shows while recruiting

NCT07130708 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 10 participants, a relatively small participant target, below the 1,502-participant average among 59 other Prostate Carcinoma trials with a reported enrollment target (99% lower).

The record links to 2 conditions, with Prostate Carcinoma appearing as the primary indexed condition, and to 1 intervention - of which Telesurgery utilizing Microport Medbot Robotic Platform is the first listed.

NCT07130708 reports a single indexed study location in Florida.

Frequently Asked Questions

What is clinical trial NCT07130708 about?

NCT07130708 is a clinical study titled "Exploring the Potential of Robotic Telesurgery in Remote Settings". This study involves a type of robotic surgery called telesurgery, where a highly trained surgeon performs the surgical procedure using a secure internet connection to operate on a patient in a different location. Urologists from The goal of this study is to find out how safe and effective telesurger...

What is the current status of trial NCT07130708?

This trial is currently recruiting. It is a NA study. The enrollment target is 10 participants. The study started on 2025-06-14. Estimated completion is 2033-07-30.

What conditions does trial NCT07130708 study?

This clinical trial studies the following conditions: Prostate Carcinoma, Prostate Disease.

What interventions are being tested in trial NCT07130708?

The interventions under investigation include: Telesurgery utilizing Microport Medbot Robotic Platform (DEVICE).

Who is sponsoring clinical trial NCT07130708?

This trial is sponsored by AdventHealth, which has 95 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT07130708 being conducted?

This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Prostate Carcinoma

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT07130708's enrollment target sits among peer trials

10 58th of 59 higher than 2 of 59 other Prostate Carcinoma trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Prostate Carcinoma trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00623389 · 10 participants · NA

    Evaluation of an Advanced Lower Extremity Neuroprostheses

  • NCT01241864 · 10 participants · Phase 2

    Islet Transplantation in Type 1 Diabetic Kidney Allograft

  • NCT01293214 · 10 participants · NA

    Vascularized Composite Allotransplantation for Multiple Extremity Amputations

  • NCT01474148 · 10 participants · NA

    A Neuroprosthesis for Seated Posture and Balance

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT07130708, the US trial registry maintained by the National Library of Medicine. NCT07130708 (small enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.